Pilot Study of BOTOX for Migraine Headaches

Stopped early · Not applicable

Conditions studied: Migraine Headache

In brief

The purposes of this study are to assess whether subjects treated with BOTOX will: 1. have a decrease in the frequency and intensity of migraine headaches 2. experience improvements in quality of life 3. experience a reduction in the frequency of health care services obtained.

Key facts

Study ID

NCT00850421

Run by

HealthPartners Institute

People needed

35

Starts

2004-04-01

Expected to finish

2010-04-01

Last updated by the study team

2018-09-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects > 18 years of age
• Subject has an established history of migraine headache, with or without aura, per IHS criteria (1.2.1 or 1.1), for at least 6 months prior to screening.
• Subject receives primary health care from Park Nicollet Health Services.

You may not qualify if…

• Subject has received previous injections of botulinum toxin of any serotype for any reason, within the 6 months prior to study participation.
• Additional eligibility will be discussed at point of contact

Where it is running

• Park Nicollet Health Services — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.